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Abstract
Background: Heterotrimeric guanine nucleotide-binding regulatory proteins (G proteins), composed of
Gα, Gβ, and Gγ subunits, are positioned at the inner face of the plasma membrane and relay signals from
activated G protein-coupled cell surface receptors to various signaling pathways. Gβ5 is the most
structurally divergent Gβ isoform and forms tight heterodimers with regulator of G protein signalling
(RGS) proteins of the R7 subfamily (R7-RGS). The subcellular localization of Gβ 5/R7-RGS protein
complexes is regulated by the palmitoylation status of the associated R7-binding protein (R7BP), a recently
discovered SNARE-like protein. We investigate here whether R7BP controls the targeting of Gβ5/R7-RGS
complexes to lipid rafts, cholesterol-rich membrane microdomains where conventional heterotrimeric G
proteins and some effector proteins are concentrated in neurons and brain.
Results: We show that endogenous Gβ5/R7-RGS/R7BP protein complexes are present in native neuron-
like PC12 cells and that a fraction is targeted to low-density, detergent-resistant membrane lipid rafts. The
buoyant density of endogenous raft-associated Gβ5/R7-RGS protein complexes in PC12 cells was similar
to that of lipid rafts containing the palmitoylated marker proteins PSD-95 and LAT, but distinct from that
of the membrane microdomain where flotillin was localized. Overexpression of wild-type R7BP, but not
its palmitoylation-deficient mutant, greatly enriched the fraction of endogenous Gβ5/R7-RGS protein
complexes in the lipid rafts. In HEK-293 cells the palmitoylation status of R7BP also regulated the lipid raft
targeting of co-expressed Gβ5/R7-RGS/R7BP proteins. A fraction of endogenous Gβ5/R7-RGS/R7BP
complexes was also present in lipid rafts in mouse brain.
Conclusion: A fraction of Gβ5/R7-RGS/R7BP protein complexes is targeted to low-density, detergent-
resistant membrane lipid rafts in PC12 cells and brain. In cultured cells, the palmitoylation status of R7BP
regulated the lipid raft targeting of endogenous or co-expressed Gβ5/R7-RGS proteins. Taken together
with recent evidence that the kinetic effects of the Gβ5 complex on GPCR signaling are greatly enhanced
by R7BP palmitoylation through a membrane-anchoring mechanism, our data suggest the targeting of the
Gβ5/R7-RGS/R7BP complex to lipid rafts in neurons and brain, where G proteins and their effectors are
concentrated, may be central to the G protein regulatory function of the complex.
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Background
Seven transmembrane-spanning receptors in eukaryotes
regulate intracellular processes in response to extracellular
signals through their interaction with signal-transducing
heterotrimeric guanine-nucleotide binding regulatory
proteins (G proteins1) [1]. cDNAs from five G protein β
subunit genes (Gβ1–5) have been identified by molecular
cloning. The Gβ5 isoform shares much less homology
with other isoforms (~50%) and is preferentially
expressed in brain [2]. A longer splice variant of Gβ5,
Gβ5L, is present in retina [3]. Gβ5 and Gβ5L, but not the
other Gβ isoforms, can form tight heterodimers with the
R7 subfamily of regulator of G protein signaling (RGS)
proteins: RGS6, 7, 9 and 11 (R7-RGS) [4-10], an interac-
tion mediated by a Gγ-like (GGL) domain present in the
R7 subfamily of RGS proteins [5,7].
The function of Gβ5/R7-RGS protein complexes in brain
and the role of the subcellular localization of the complex
in such function are unclear. We previously demonstrated
the multi-compartmental subcellular localization of Gβ5
and R7 proteins to the plasma membrane, cytosol, and
cell nucleus in neurons and brain using subcellular frac-
tionation and confocal microscopy [11]. We also found
that the interaction of Gβ5 with the GGL-domain contain-
ing RGS proteins directs its nuclear localization [12]. Pre-
vious work with recombinant Gβ5-RGS7 complex
expressed in Sf9 insect cells suggested it was the palmi-
toylation status of RGS7 that determined the membrane
versus cytosolic localization of the complex [13]. More
recently an R7 binding protein (R7BP) was discovered
that binds tightly to Gβ5-R7 protein complexes [14,15].
R7BP is itself palmitoylated and can regulate the nuclear
localization of the Gβ5/R7-RGS/R7BP protein complex
based on the palmitoylation status of R7BP [15,16]. In its
palmitoylated form, R7BP anchors Gβ5 protein com-
plexes to the plasma membrane, and depalmitoylation of
R7BP promotes translocation of Gβ5/R7-RGS/R7BP com-
plexes to the nucleus via a polybasic nuclear localization
signal (NLS) present near the C-terminus of R7BP [15-17].
These data invite further investigation into the nature of
the membrane localization of Gβ5/R7-RGS/R7BP com-
plexes.
To gain further insight into the effects of R7BP palmitoyla-
tion on the membrane targeting of Gβ5/R7-RGS/R7BP
complexes we studied wild-type R7BP and the palmitoyla-
tion-deficient R7BP mutant proteins in transfected PC12
and HEK-293 cells. PC12 cells have neuron-like features
including the ability to synthesize dopamine and nore-
pinephrine and to express receptors for nerve growth fac-
tor, while HEK-293 have a non-neuronal phenotype. We
report that Gβ5/R7-RGS/R7BP complexes localize to lipid
raft microdomains in membranes from both cell types
and in adult mouse brain and that the palmitoylation sta-
tus of R7BP appears to control such lipid raft association.
Together with recent evidence showing the regulatory
effects of the Gβ5 complex on GPCR signaling are greatly
enhanced by R7BP palmitoylation and membrane
anchoring [17], our data suggests the targeting of the Gβ5/
R7-RGS/R7BP complex to lipid rafts in neuronal cells may
be critical for the G protein-directed function of the com-
plex.
Results
Localization of endogenous Gβ5 and RGS7 to lipid raft 
membrane domains in native PC12 cells requires 
palmitoylation
The recently discovered R7BP is a SNARE-like protein with
twin C-terminal cysteine residues that are covalently mod-
ified by palmitoylation [14,15]. R7BP binds tightly to
Gβ5/R7-RGS protein complexes and can regulate the sub-
cellular distribution of the Gβ5/R7-RGS/R7BP protein
complex based on its palmitoylation status [15,16]. The
covalent fatty acylation of several signalling proteins with
palmitate results promotes their targeting to lipid rafts,
plasma membrane microdomains enriched in cholesterol
and glycosphingolipids (reviewed in [18,19]). Such pro-
teins include H-Ras [20] and certain dually acylated heter-
otrimeric G protein α subunits [21].
The dual palmitoylation of R7BP would make it a candi-
date for lipid raft targeting and we therefore looked for
evidence of such targeting by established biochemical
methods using neuron-like PC12 cells as an initial model
system. Protein subunits encoding the Gβ5/R7-RGS/R7BP
complex components are expressed in PC12 cells but not
in non-neuronal HeLa (Fig. 1A) or HEK-293 cells (not
shown) consistent with previous results [11]. In order to
isolate lipid rafts we analyzed Triton-X-100 solubilizates
on discontinuous sucrose density gradients by ultracen-
trifugation. The low buoyant density of detergent-resistant
membranes (DRMs), which are aggregates of lipid rafts
[22], causes them to float towards the top of sucrose gra-
dients while detergent-soluble proteins are distributed
toward the bottom. In the discontinuous sucrose density
gradient methodology employed here for cultured cells,
we used established lipid raft markers including flotillin-
1 and linker for activation of T cells (LAT) (Fig. 1B)
[23,24]. Another positive control for lipid raft isolation
was the PSD-95 protein (Fig. 1B). PSD-95 is found in the
brain localized to both synaptic lipid rafts and postsynap-
tic densities [25,26], membrane compartments between
which certain protein components may communicate
[27].
Using the discontinuous sucrose density gradient analysis,
we estimate that 10 to 20% of endogenous Gβ5 and RGS7
proteins in naïve PC12 cells are localized to the lipid raft
fractions (Fig. 1C and 1D). The low-density peak ofBMC Biochemistry 2007, 8:18 http://www.biomedcentral.com/1471-2091/8/18
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endogenous RGS7 and Gβ5 proteins comigrates with the
LAT and PSD-95 marker peaks in fractions 3 and 4 of the
discontinuous sucrose gradient, comigrating also with the
flotillin in fraction 3 just behind the peak of the flotillin
marker in fraction 2. The bulk of the Gβ5/RGS7 proteins
is found in the heavier sucrose fractions however, and
comigrates with the Na-K ATPase β2 subunit marker used
as a non-lipid raft negative control (Fig. 1B, C, D). Over-
night treatment of PC12 cells with 2-bromopalmitate to
block palmitoylation of endogenous proteins prevented
targeting of the native Gβ5/RGS7 complex to the raft frac-
tions, instead targeting the endogenous complex to the
cell nucleus (not included in the gradient fractions) (data
not shown), as previously demonstrated for transfected
Gβ5/RGS9-1/GFP-R7BP complexes [15,17]. Taken
together these results indicate that approximately 10 to
20% of endogenous Gβ5/RGS7 protein complexes in
naïve PC12 cells are localized to a type of lipid raft with
buoyant density similar to the lipid rafts containing the
palmitoylated marker proteins PSD-95 and LAT, but dis-
tinct from the membrane microdomain where flotillin is
localized. The localization of the Gβ5/RGS7 protein com-
plex to the lipid raft fraction may require the palmitoyla-
tion of one or more endogenous proteins such as R7BP. In
these experiments, the detection of endogenous R7BP in
the sucrose gradient fractions from PC12 cells was not
possible with the currently available antibodies due to the
low levels of protein when diluted across the gradient.
The palmitoylation status of R7BP governs partitioning of 
the Gβ5/R7-RGS complex to a Triton-insoluble fraction in 
PC12 cells
The above results suggest that palmitoylation is required
for the lipid raft targeting of native Gβ5/R7-RGS protein
complexes but do not identify which palmitoylated pro-
tein(s) may be necessary for such targeting. We first inves-
tigated the role of the palmitoylated anchor protein R7BP
in targeting Gβ5/R7-RGS protein complex to DRMs. To
this end, we increased the expression level of R7BP by
overexpressing either wild-type or mutant R7BP and
checked their ability to interact with endogenous Gβ5/R7-
RGS protein complexes and their subcellular localization.
Both wild-type R7BP and the previously described palmi-
toylation-deficient R7BP- C252S/C253S double mutant
(R7BP-SS) were readily expressed in PC12 cells in N-ter-
minal HA epitope tagged form (Fig. 2A, upper) [15].
Immunoprecipitation of the transfected epitope-tagged
R7BP constructs demonstrated their tight binding to, and
co-immunoprecipitation with, endogenous Gβ5 and
RGS7 (Fig. 2A, lower), consistent with previous reports
employing non-palmitoylated R7BP mutants [14,15].
Subcellular fractionation of PC12 cells transfected with
R7BP or R7BP-SS demonstrated differential localization
of the wild-type and mutant proteins. Wild-type R7BP
localized to the post-nuclear crude membrane fraction
(Fig. 2B, center column), while the R7BP-SS mutant local-
ized predominantly to the cytosolic and nuclear fractions
(Fig. 2B, right-hand column; Fig. 3A, bottom panels). In
order to better define the subcellular targeting of trans-
fected R7BP and R7BP-SS in PC12 cells, we further ana-
lyzed their expression by laser confocal microscopy (Fig.
3B). The wild-type R7BP expressed in transfected PC12
Localization of endogenous Gβ5/RGS7 complexes to lipid  rafts in PC12 cells Figure 1
Localization of endogenous Gβ5/RGS7 complexes to 
lipid rafts in PC12 cells. A. Gβ5/RGS7/R7BP proteins are 
expressed endogenously in PC12 cells. Hela and PC12 cells 
were lysed and samples were loaded in SDS-PAGE gels and 
subjected to immunoblotting using anti-R7BP (N-terminal), 
anti-RGS7, anti-Gβ5, and actin antibodies as described in 
Methods. The relative mobility of the major immunoreactive 
bands (in kDa) is indicated on the right. B. Determination of 
DRM (lipid raft) and non-DRM markers along a sucrose den-
sity gradient in PC12 cells. The DRM (lipid rafts) were iso-
lated using a sucrose density gradient prepared by 
ultracentrifugation as detailed in Methods. Fractions were 
analyzed by immunoblotting for flotillin-1, LAT and PSD-95 
as markers for DRM and the β2 subunit of Na-K ATPase as a 
non-DRM marker. Fractions 1–5 were enriched in the DRM 
marker, while fractions 6–10 carried the non-DRM marker. 
C. Localization of endogenous Gβ5 and RGS7 proteins in 
PC12 cells. PC12 cells were lysed, and subjected to a sucrose 
density gradient. Equal aliquots from all ten fractions were 
subjected to SDS-PAGE followed by immunoblotting for the 
endogenous Gβ5 and RGS7 proteins as indicated. D. Densit-
ometric quantification of the distribution of endogenous Gβ5 
and RGS7 proteins among DRM and non-DRM fractions in 
sucrose density gradients. Immunoblots of sucrose density 
gradients such as that shown in C were analyzed by densit-
ometry and the distribution of the indicated immunoreactiv-
ity between DRM and non-DRM fractions (as % of total 
immunoreactivity with that antibody) is shown as a histogram 
to the right of the corresponding immunoblots, with error 
bars representing the S.E.M. The results shown are repre-
sentative of three experiments completed with similar 
results.
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cells excluded the cell nuclei that were directly identified
by counterstaining with Hoechst reagent (Fig. 3B, middle
column), consistent with the localization of endogenous
R7BP in NG108-15 cells [16]. In contrast, the palmitoyla-
tion-deficient R7BP-SS mutant localized throughout the
cells including the entire PC12 cell nucleus (Fig. 3B, right
hand column). These findings are consistent with the pre-
viously described subcellular localization of wild-type
and non-palmitoylated R7BP mutant proteins expressed
in cultured cells and neurons [15,16].
Because the insolubility of dually palmitoylated lipid raft-
associated proteins in ice-cold Triton X-100 has been used
previously in PC12 cells to define and isolate lipid rafts
[28], we tested whether transfected R7BP could influence
the distribution of endogenous Gβ5/R7-RGS proteins to
these membrane microdomains. PC12 cells transfected
with vector alone, HA-R7BP, or HA-R7BP-SS were
extracted with cold Triton X-100 and separated into solu-
Subcellular distribution of wild-type and mutant R7BP in  PC12 cells Figure 3
Subcellular distribution of wild-type and mutant 
R7BP in PC12 cells. A. Cytoplasmic and nuclear distribu-
tion of transfected wild type R7BP or non-palmitoylated 
mutant R7BP in PC12 cells. Cytoplasmic and nuclear frac-
tions were prepared from PC12 cells transfected with the 
cDNAs indicated on the left. Immunoblots to monitor HA-
R7BP expression, α-tubulin expression as a marker for the 
cytosolic fraction, and p84/N5 expression as marker for the 
nuclear fraction are shown. B. Immunocytofluorescent locali-
zation of R7BP in PC12 cells. PC12 cells transfected with 
vector (panels in left column), wild type (wt) HA-R7BP (mid-
dle column) or HA-R7BP SS (right column), were subjected 
to the immunostaining using anti-HA primary antibody and 
fluorescein isothiocyanate (FITC)-conjugated donkey anti-
mouse IgG antibody (green signal) as a secondary antibody. 
The Hoechst 33342 nuclear dye (blue signal) was used to 
counterstain transfected PC12 cells. The single or combined 
(merge) fluorescent signal was recorded by laser confocal 
microscopy. The results shown are representative of three 
total experiments performed with similar findings.
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RGS7 proteins of wild-type and mutant R7BP in 
PC12 cells. A. Co-immunoprecipitation of endogenous 
Gβ5/RGS7 with transfected R7BP constructs in PC12 cells. 
Cells were transfected with pcDNA3 (vector), wild type (wt) 
HA-R7BP, or the non-palmitoylated HA-R7BP-SS mutant 
cDNAs. The detergent lysate was immunoprecipitated using 
anti-HA antibody. The whole cell lysate (upper) and the pre-
cipitated proteins (lower) were analyzed by immunoblotting 
using anti-HA, anti-RGS7, and anti-Gβ5 (ATDG) antibodies 
as shown. The relative mobility of the major immunoreactive 
bands (in kDa) and the immunoglobulin heavy chain (HC) are 
indicated on the right. B. Fractionation analysis of PC12 cells 
transfected with wild type R7BP or its non-palmitoylated 
mutant. PC12 cells transfected with pcDNA3 (vector), wild 
type (wt) HA-R7BP, or the non-palmitoylated HA-R7BP-SS 
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ble and insoluble fractions (Fig. 4A). Immunoblotting
showed that the transfected wild-type R7BP was found
largely in the insoluble fraction while most of the R7BP-
SS was soluble (Fig. 4A, cf. lanes 2 and 3). Furthermore
while the bulk of the endogenous PC12 Gβ5 and RGS7
proteins were in the soluble fraction in the control and
R7BP-SS transfected cells, some 40% of the endogenous
Gβ5 and RGS7 shifted to the Triton-insoluble fraction
when wild-type R7BP was transfected (Fig. 4A lane 2, cf.
lanes 1 and 3; Fig. 4B). No shift to the Triton-insoluble
fraction of α-tubulin, which is not a component of Gβ5/
R7-RGS protein complexes with R7BP, was observed (Fig.
4A).
R7BP regulates the targeting of Gβ5 and RGS7 to lipid raft 
membrane domains
The Triton-insoluble pellet fraction contains aggregates of
DRMs as well as non-raft associated detergent insoluble
proteins [22]. To investigate whether the shift of endog-
enous of Gβ5/R7-RGS complexes to the detergent-insolu-
ble fraction resulting from overexpression of wild type
R7BP in PC12 cells reflects a shift of the complex to lipid
rafts, the distribution of HA-R7BP and endogenous Gβ5
and RGS7 proteins along a sucrose density gradient was
determined (Fig. 5). In control (vector-only) transfected
PC12 cells a peak of endogenous Gβ5 and RGS7 was
found in fractions 3 and 4 with the DRMs, while the vast
Effect of R7BP on the distribution of the endogenous Gβ5/ RGS7 complex among detergent-resistant membrane (DRM)  and non-DRM fractions in PC12 cells Figure 5
Effect of R7BP on the distribution of the endogenous 
Gβ5/RGS7 complex among detergent-resistant 
membrane (DRM) and non-DRM fractions in PC12 
cells. A. Determination of DRM (lipid raft) and non-DRM 
markers along a sucrose density gradient in vector-trans-
fected PC12 cells. The DRM (lipid rafts) were isolated using a 
sucrose density gradient prepared by ultracentrifugation as 
detailed in Methods. Fractions were analyzed by immunob-
lotting for flotillin-1 as a marker for DRM and the β2 subunit 
of Na-K ATPase as a non-DRM marker. Fractions 1–5 were 
enriched in the DRM marker, while fractions 6–10 carried 
the non-DRM marker. B. Localization of endogenous Gβ5 
and RGS7 proteins in control PC12 cells transfected with 
empty pcDNA3-HA vector (vector only). PC12 cells were 
transfected with empty vector, lysed, and subjected to a 
sucrose density gradient centrifugation. Equal aliquots from 
all ten fractions were subjected to SDS-PAGE followed by 
immunoblotting for the endogenous Gβ5 and RGS7 proteins 
as indicated. Immunoblots of the sucrose density gradients 
shown were analyzed by densitometry and the distribution of 
the indicated immunoreactive bands between DRM and non-
DRM fractions (as % of total immunoreactivity with that anti-
body) is shown as a histogram to the right of the corre-
sponding immunoblot, with error bars representing the 
S.E.M. C. Localization of endogenous Gβ5 and RGS7 proteins 
in PC12 cells expressing wild type (wt) HA-R7BP. PC12 cells 
were transfected with wt HA-R7BP and analyzed as indicated 
in the legend to B. D. Localization of endogenous Gβ5 and 
RGS7 proteins in PC12 cells expressing the non-palmi-
toylated HA-R7BP-SS mutant. PC12 were transfected with 
HA-R7BP-SS and analyzed as indicated in the legend to B. 
These results are representative of three total such experi-
ments performed with similar findings.
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majority of Gβ5/RGS7 immunoreactivity was found in
fractions 6–10 among non-raft proteins (Fig. 5B), similar
to the results in native PC12 cells (Fig. 1C). Approxi-
mately half of transfected wild-type R7BP migrates with
the DRMs, and causes a major shift of endogenous Gβ5
and RGS7 proteins into fractions 1–5 as well (Fig. 5C). In
contrast, transfected R7BP-SS was found in the heavier
sucrose fractions with non-raft membrane protein mark-
ers and caused no shift of endogenous Gβ5 and RGS7 pro-
teins into the DRM fractions (Fig. 5D). These results were
entirely consistent with the cold Triton X-100 extraction
data presented above and suggest the palmitoylation sta-
tus of R7BP can govern the distribution of Gβ5/R7-RGS/
R7BP complexes into or out of lipid raft membrane micro-
domains.
Since neuron-like PC12 cells contain endogenous Gβ5
and RGS7 proteins [11,12], we wondered whether the
effect of R7BP on lipid raft targeting could be verified in a
non-neuronal cell line in which the components of Gβ5/
R7-RGS/R7BP complexes were re-constituted by transfec-
tion. For this reason we analyzed the distribution of trans-
fected R7BP, Gβ5 and RGS7 proteins in Triton X-100
extracts along a sucrose density gradient in HEK-293 cells
(Fig. 6). HEK-293 cells were shown previously to lack sig-
nificant expression of Gβ5 mRNA and protein [29]. As
markers for DRM and non-DRM fractions in HEK-293
cells, the migration of the dually acylated kinase Fyn and
the α1 subunit of Na-K ATPase, respectively, were deter-
mined by immunoblotting (Fig. 6A). Transfection of AU5
epitope-tagged Gβ5 and RGS7, without R7BP, resulted in
no significant targeting of Gβ5/RGS7 complexes to the
DRM fractions (Fig. 6B). On the other hand co-transfec-
tion of wild-type R7BP (Fig. 6C), but not the non-palmi-
toylated R7BP-SS mutant (Fig. 6D), with AU5-Gβ5 and
RGS7 resulted in a shift of approximately 60% of the Gβ5/
R7-RGS/R7BP complexes to the DRM fractions (Fig. 6C).
When wild-type R7BP was employed, the peak of the low-
density component of Gβ5/R7-RGS/R7BP complex pro-
teins was in fractions 3 and 4 of the HEK-293 cell sucrose
gradient (Fig. 6C), just as in PC12 cells. These findings
show that, just as in neuronal PC12 cells that express the
endogenous Gβ5 complex, in HEK-293 cells the palmi-
toylation status of R7BP can govern the distribution of
Gβ5/R7-RGS/R7BP complexes into or out of lipid raft
membrane microdomains.
Endogenous mouse brain Gβ5, RGS7 and R7BP localize to 
lipid raft membrane domains
Since the fraction of endogenous Gβ5/R7-RGS protein
complexes in neuron-like PC12 cells localized to the lipid
rafts could be greatly increased by overexpression of wild-
type R7BP, we investigated the localization of Gβ5/R7-
RGS protein complexes in native brain where R7BP is
most highly expressed [14,15]. Because of the high lipid
and protein content of brain compared to cultured cells, a
different sucrose density gradient protocol was utilized,
resulting in 11 fractions per gradient [26,30]. After extrac-
tion of DRMs from a synaptosomal fraction of mouse
brain, we found that a readily detectable fraction of
endogenous brain Gβ5/RGS7/R7BP protein complexes
localized to lipid raft fractions that comigrated with the
flotillin marker (Fig. 7). As in neuronal PC12 cells, the
Effect of R7BP on the distribution of the Gβ5/RGS7 complex  among detergent-resistant membrane (DRM) and non-DRM  fractions in HEK-293 cells Figure 6
Effect of R7BP on the distribution of the Gβ5/RGS7 
complex among detergent-resistant membrane 
(DRM) and non-DRM fractions in HEK-293 cells. A. 
Determination of endogenous DRM (lipid raft) and non-DRM 
markers along a sucrose density gradient in HEK-293 cells. 
The DRM (lipid rafts) were isolated using a sucrose density 
gradient prepared by ultracentrifugation. Fractions were ana-
lyzed by immunoblotting for Fyn as a marker for DRM and 
the α1 subunit of Na-K ATPase as a non-DRM marker. Frac-
tions 1–5 were enriched in the DRM marker, while fractions 
6–10 carried the non-DRM marker. B. Localization of trans-
fected AU5-Gβ5 and RGS7 proteins in HEK-293 cells. Cells 
were transfected with the indicated constructs, lysed and 
subjected to a sucrose density gradient centrifugation. Equal 
aliquots from all ten fractions were subjected to SDS-PAGE 
followed by immunoblotting for the transfected Gβ5 and 
RGS7 proteins as indicated. Immunoblots of the sucrose den-
sity gradients shown were analyzed by densitometry and the 
distribution of the indicated immunoreactive bands between 
DRM and non-DRM fractions (as % of total immunoreactivity 
with that antibody) is shown as a histogram to the right of 
the corresponding immunoblot, with error bars representing 
the S.E.M. C. Localization of co-transfected wild type HA-
R7BP, AU5-Gβ5 and RGS7 proteins in HEK-293 cells. Cells 
were co-transfected as indicted and analyzed as indicated in 
the legend to panel B. D. Localization of co-transfected HA-
R7BP-SS, AU5-Gβ5 and RGS7 proteins in HEK-293 cells. 
Cells were co-transfected as indicated and analyzed as indi-
cated in the legend to panel B. These results are representa-
tive of four total such experiments performed with similar 
findings.
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bulk of brain Gβ5/RGS7/R7BP protein complexes distrib-
uted to the bottom gradient fractions where the non-raft
protein transferrin receptor (TfR) marker is found (Fig. 7).
In this sucrose density gradient protocol there is large
component of incompletely solubilized synaptosomes
that is represented in fraction 11, accounting for the heavy
staining of marker and Gβ5/RGS7/R7BP proteins in this
fraction.
Discussion
It has been proposed that lipid rafts provide a concentrat-
ing platform for the efficient interaction of certain recep-
tors and other signaling proteins [18,19,22]. The recently
discovered Gβ5/R7-RGS anchoring protein R7BP, and its
retinal paralog R9-anchoring protein, show structural
similarity to the soluble N-ethylmaleimide-sensitive fac-
tor attachment protein receptor (SNARE) complex protein
syntaxin [14,31]. SNARE complex proteins including syn-
taxin are highly enriched in lipid rafts [32]. Furthermore
the dual palmitoylation of R7BP makes it a logical candi-
date for lipid raft targeting, given that the covalent fatty
acylation of several signalling proteins with palmitate pro-
motes their targeting to lipid rafts, including dually
acylated heterotrimeric G protein α subunits [21]. The
data presented here demonstrate that indeed the Gβ5/R7-
RGS/R7BP complex associates with lipid rafts in native
PC12 cells and mouse brain, and that targeting to these
liquid-ordered membrane microdomains is supported by
the wild-type, but not the non-palmitoylated mutant
form of R7BP.
The present work shows that some 10–30% of endog-
enous Gβ5/R7-RGS/R7BP complexes are lipid raft-associ-
ated in native PC12 cells and brain. The data presented
here suggest that R7BP and its palmitoylation status are
the major determinants of the lipid raft association of
Gβ5/R7-RGS/R7BP complexes. However, since a previous
report found no significant association of RGS7 with lipid
rafts in bovine brain membranes [13], it seems possible
that additional signal(s) besides palmitoylation may be
required to enhance the lipid raft targeting of the Gβ5/R7-
RGS complex in native membranes. In photoreceptors for
example the paralogous complex in the outer segments
containing the retina-specific isoforms of Gβ5 and RGS9
undergoes a dramatic shift to the lipid raft membrane
fraction only upon illumination, the external signal that
initiates the phototransduction cascade [33]. By analogy
with the retinal system, it may be that yet-to-be-identified
external signal(s) regulate the concerted movement of
neuronal Gβ5/R7-RGS/R7BP complexes to lipid rafts. The
partitioning of these complexes to lipid rafts under basal
conditions may be minimal.
The range of signal(s) that may control Gβ5/R7-RGS/
R7BP complex subcellular localization and function is
currently unknown. A recent study by Song and coworkers
showed the importance of the R7BP C-terminal domain
in the targeting Gβ5-RGS9-2 complexes to the plasma
membrane and the nucleus, and demonstrated that a sig-
nificant fraction of Gβ5/RGS9-2 is found in neuronal
postsynaptic densities (PSD) [16]. The neuronal scaffold-
ing protein PSD-95, though first identified and named for
its association with PSD, is also highly enriched in rat
brain synaptosomal lipid raft fractions [26], consistent
with our results here showing that Gβ5/R7-RGS com-
plexes comigrate with PSD-95 and LAT in the lipid raft
fraction of PC12 extracts. The study by Song and cowork-
ers did not address the localization of Gβ5/R7-RGS/R7BP
complexes to lipid rafts [16]. Nevertheless the likelihood
of functional connection between lipid rafts and PSD in
the postsynaptic region of neurons makes the co-localiza-
tion of Gβ5/R7-RGS/R7BP complexes to both lipid rafts
and PSD a distinct possibility [26,27].
Distribution of endogenous Gβ5/RGS7/R7BP among deter- gent-resistant membrane (DRM) and non-DRM fractions of  mouse brain membranes Figure 7
Distribution of endogenous Gβ5/RGS7/R7BP among 
detergent-resistant membrane (DRM) and non-DRM 
fractions of mouse brain membranes. A. Analysis of 
endogenous marker proteins in DRM and non-DRM fractions 
from mouse brain. Equal volumes of gradient fractions were 
analyzed by immunoblotting for flotillin-1, as marker for 
DRM, and the transferrin receptor (TfR) as a non-DRM 
marker. B. Sucrose density gradient analysis of endogenous 
Gβ5, RGS7, and R7BP synaptosomal membrane proteins in 
mouse brain. A detergent extract of mouse brain synapto-
somes was subjected to a sucrose density gradient fractiona-
tion. Equal aliquots from all eleven fractions were subjected 
to SDS-PAGE followed by immunoblotting for the endog-
enous Gβ5, RGS7, and R7BP (using antibody TRS) proteins 
as indicated. Immunoblots of the sucrose density gradients 
shown were analyzed by densitometry and the distribution of 
the indicated immunoreactive bands between DRM and non-
DRM fractions among (as % of total immunoreactivity with 
that antibody) is shown as a histogram to the right of the 
corresponding immunoblot, with error bars representing the 
S.E.M.
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While the possible biological significance of Gβ5/R7-
RGS/R7BP complex targeting to lipid rafts is presently
unknown, strong clues can be assembled from currently
available evidence. The most likely physiological target of
Gβ5/R7-RGS/R7BP complex GTPase activating protein
(GAP) activity, heterotrimeric Gαo [9,13,34], is acylated
by both myristate and palmitate and is lipid raft-associ-
ated [21,28,35]. Recent studies in Xenopus laevis oocytes
showed the regulatory effect of the Gβ5 complex on Gαi/
o-coupled m2 muscarinic receptor signaling, typical of
RGS protein-mediated Gαi/o-directed GAP action, was
greatly enhanced by R7BP palmitoylation [15]. Further-
more the functional enhancement of R7BP due to palmi-
toylation in this pathway was a result of its membrane
anchoring [17]. In light of these findings, our data suggest
the targeting of the Gβ5/R7-RGS/R7BP complex to lipid
rafts in neurons and brain, where G proteins and their
effectors are concentrated, may be central to the G protein
regulatory function of the complex.
Conclusion
In both neuron-like PC12 cells and mouse brain, a frac-
tion of endogenous Gβ5/R7-RGS/R7BP protein com-
plexes is targeted to low-density, detergent-resistant
membrane lipid rafts. In cultured PC12 and HEK-293
cells, the palmitoylation status of R7BP regulated the lipid
raft targeting of endogenous or co-expressed Gβ5/R7-RGS
proteins. Taken together with recent evidence that the
kinetic effects of the Gβ5 complex on GPCR signaling are
greatly enhanced by R7BP palmitoylation through a
membrane-anchoring mechanism, our data suggest the
targeting of the Gβ5/R7-RGS/R7BP complex to lipid rafts
in neurons and brain, where G proteins and their effectors
are concentrated, may be central to the G protein regula-
tory function of the complex.
Methods
Plasmid construction and antibodies
A cDNA encoding human R7BP was prepared from
pCMV6-XL4 (GenBank XM_059682; Origene No.
TC103542) by PCR subcloning of residues 2 to 257 into
the BamHI (5') and EcoRI (3') sites of pcDNA3-HA vector
thereby adding an in-frame N-terminal hemagglutinin
(HA) 9-residue epitope tag (YPYDVPDYA). The C252S/
C253S non-palmitoylated R7BP mutant (R7BP-SS), as
described by Drenan and coworkers [15], was prepared
using the QuickChange II Site-Directed Mutagenesis Kit
(Stratagene) with the HA-tagged wild-type R7BP in
pcDNA3 as the template. An AU5 epitope-tagged mouse
Gβ5 cDNA was prepared by PCR subcloning of residues 2
-353 into the BamHI (5') and EcoRI (3') sites of pcDNA3-
AU5 vector thereby adding an in-frame N-terminal AU5 6-
residue epitope tag (TDFYLK). The expression construct
encoding full-length bovine RGS7 in pcDNA4-HisMax-C
(that adds an in-frame Xpress epitope and His-6 tag) was
previously described [12]. The coding sequence of all con-
structs was confirmed by DNA sequencing. The primary
antibodies used for immunoblotting were: mouse anti-
HA monoclonal antibody (cat. No. MMS-101R, Cov-
ance), mouse anti-AU5 monoclonal antibody (cat. No.
MMS-135R, Covance), affinity-purified rabbit ATDG pol-
yclonal antibody against the N terminus of Gβ5 [10],
purified IgG fraction of rabbit 7RC-1 polyclonal antibody
anti-RGS7 [12], anti-R7BP N-terminal rabbit antibody (a
generous gift from Dr. Kirill Martemyanov), anti-R7BP
rabbit polyclonal antibody TRS (raised against the syn-
thetic peptide CTRSSIFQISKPPLQSGDWERRG-amide
(corresponding to residues 16 to 37 of human/mouse
R7BP, with an added N-terminal cysteine) coupled to
maleimide-activated KLH (Pierce), and affinity-purified
on a column of synthetic peptide covalently bound to
Ultralink Iodoacetyl Gel (Pierce)), mouse anti-flotillin-1
monoclonal antibody (cat. no. 610821, BD Transduction
Laboratories), anti-LAT polyclonal rabbit IgG (cat. no.
AB4093, Chemicon), anti-PSD-95 affinity-purified poly-
clonal rabbit antibody (cat. no. AB9634, Chemicon), anti-
Na/K ATPase α1 subunit (cat. no. 06–520, Upstate Bio-
technology), anti-Na/K ATPase β2 subunit (cat. no.
A3979, Sigma), anti-transferrin receptor (TfR) (cat no.
13–6800, Zymed), mouse anti α-tubulin monoclonal
antibody (cat. no. CP06, Calbiochem), and mouse anti-
p84/N5 5E10 monoclonal (cat. no. MS-P8410-PX1,
GeneTex). Secondary HRP-conjugated polyclonal anti-
bodies employed were goat anti-mouse (cat. no.
1858413, Pierce Biotechnology) and goat anti-rabbit (cat.
no. AP311, The Binding Site).
Cell Culture
Rat pheochromocytoma PC12 cells (cells that synthesize
dopamine and norepinephrine and express receptors for
nerve growth factor, neuron-like features) were grown in
75 cm2 flasks at 37°C and 5 % CO2 containing DMEM
supplemented with 10 % horse serum, 5 % fetal bovine
serum, 4 mM L-glutamine, 1 × penicillin/streptomycin
(Biofluids, Rockville, MD) without nerve growth factor
(supplemented DMEM). HEK-293 cells were grown under
the same conditions as PC12 cells in DMEM supple-
mented with 10% fetal bovine serum, 4 mM L-glutamine
and 1 × penicillin/streptomycin.
Transient Expression of HA-R7BP (wild-type or -SS 
mutant) in PC12 cells, or RGS7 and Gβ5 without or with 
HA-R7BP (wild-type or -SS mutant) in HEK-293 cells
One day prior to transient transfection of HA-tagged wild-
type or mutant R7BP, PC12 cells at 80 %-90 % confluence
were plated in 75 cm2 flask containing 15 ml supple-
mented DMEM without the addition of 1 × penicillin/
streptomycin. After overnight incubation of the cells, 25
µg of plasmid DNA and 60 µl of Lipofectamine 2000 rea-
gent (Invitrogen), diluted in 3 ml of Opti-MEM I mediumBMC Biochemistry 2007, 8:18 http://www.biomedcentral.com/1471-2091/8/18
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(Gibco), were mixed, incubated at room temperature for
20 min, and added to each flask. The culture was incu-
bated for 24 h in the same condition as mentioned above.
Transfection of HEK-293 cells with RGS7 and Gβ5 with-
out or with HA-tagged wild-type or mutant R7BP was per-
formed using the same method. The expression of the
transfected proteins was verified by immunoblotting and/
or immunofluorescence.
Gel Electrophoresis, immunoblotting and 
immunoprecipitation
Protein samples were separated on 4–20 % Tris-glycine
gradient gels (Invitrogen) by SDS-polyacrylamide gel elec-
trophoresis and transferred to a nitrocellulose membrane
for 2 hr at 30 V in an XCell II Blot Module (Invitrogen).
The membranes were blocked overnight in 5% milk in
PBS containing 0.1% (v/v) Tween-20 (PBS/Tween). The
next day the membranes were incubated with the primary
antibody diluted into PBS/Tween for 30 min at room tem-
perature. After rinsing in PBS/Tween, membranes were
incubated with secondary antibody conjugated to HRP in
PBS/Tween for 30 min at room temperature and rinsed
again with PBS/Tween. The signal was detected using
SuperSignal West Dura (cat. No. 34075, Pierce). Immuno-
precipitation with anti HA antibody was performed
according to the manufacturer's instructions (Immuno-
precipitation Starter Pack, Cat. No. 309410, Amersham
Biosciences). Briefly, after transfection and 24 h incuba-
tion, PC12 cells were lysed with buffer A (250 mM NaCl,
50 mM Tris, pH 8.0, 5 mM EDTA, 0.5 % NP-40 and 1 ×
complete protease inhibitor cocktail [cat. no. 1836170,
Roche]). The lysate was centrifuged at 12,000 × g for 10
min at 4°C. The supernatant was incubated overnight
with anti-HA antibody at 4°C. The mixture was then incu-
bated with protein G-Sepharose beads previously equili-
brated in buffer A for 2 hours with rocking at 4°C. The
beads were then collected by centrifugation at 12,000 × g
for 1 min, and washed 3 times with buffer A with harvest-
ing of the beads by re-centrifugation, and the washes dis-
carded. Proteins were eluted from the beads with SDS
sample buffer and detected by immunoblotting.
Immunofluorescence
PC12 cells were transfected as described above in cham-
bers of poly-D-lysine-coated chamber slides (Nalge Nunc,
No. 154941) and incubated for 24 h. The culture medium
was discarded and the cells were rinsed with PBS and fixed
in 4% formaldehyde for 30 min. The slides were rinsed
with PBS and incubated with PBS containing 0.5% Triton
X-100 for 5 min at room temperature. The slides were
rinsed 3 times with PBS and blocked in blocking buffer
(PBS containing 0.1% Triton X-100 and 1% BSA for 1 h at
37°C). Blocking buffer was discarded and the slides were
incubated with the primary antibody diluted in blocking
buffer for 1 h at 37°C. The slides were rinsed with washing
buffer (PBS containing 0.1% Triton X-100) and incubated
with the secondary antibody (Fluorescein isothiocyanate-
conjugated donkey anti-mouse IgG, Jackson ImmunoRe-
search Labs, West Grove, PA) diluted in the blocking
buffer for 1 h at 37°C. The slides were rinsed with washing
buffer and Hoechst 33342 DNA-intercalating dye (0.5 µg/
ml in PBS) was added to the cells in order to provide
nuclear counterstaining. The cells were rinsed with PBS
and one drop of mounting medium was added on the top
of each slide. Finally the slides were covered with cover
slide and confocal images were collected on a Leica SP2-
UV 405 confocal microscope (Leica Microsystems, Exton,
PA, USA).
Cell Fractionation and Protein Determination
For separation of cytosol from a crude post-nuclear mem-
brane fraction, PC12 cells were washed twice with cold
PBS and harvested by centrifugation at 1,000 × g for 3 min
at 4°C. Cell pellets were homogenized in a glass Dounce
tissue grinder in hypotonic buffer consisting of 10 mM
HEPES pH 7.5, 50 mM mannitol, 1 mM EDTA, 10 µg/ml
soybean trypsin inhibitor, 0.5 µg/ml leupeptin, 2 µg/ml
aprotonin and 1 µM pepstatin and then centrifuged at
1,000 × g for 3 min to remove unbroken cells and nuclei.
The post-nuclear supernatant was separated into particu-
late and soluble fractions by centrifugation at 100,000 × g
for 1 h as described [36]. For separation of cytosol and the
nuclear fraction, the NE-PER kit (Pierce, No. 78833) was
used according to the manufacturer's directions. The pro-
tein concentration in the different fractions was deter-
mined using the Bio-Rad protein assay kit with BSA as the
standard.
Triton X-100 solubilization experiments
Triton X-100 soluble and insoluble cell fractions were sep-
arated by the method of Fukata and coworkers [37]. The
supernatant (Triton X-100 soluble) was separated from
the pellet (Triton X-100 insoluble) by centrifugation at
20,000 × g for 10 min at 4°C. The supernatants were col-
lected and the pellets were resuspended in SDS sample
buffer in a volume equal to the volume of supernatant
removed. Equal volumes of the supernatant and pellet
fractions were then loaded in SDS-PAGE and proteins
were analyzed by immunoblotting.
Preparation of detergent-resistant membranes (DRMs) 
from PC12 and HEK-293 cells
DRMs were prepared by discontinuous sucrose density
gradient centrifugation as described previously, with
minor modifications [38,39]. Without transfection (for
native cell membranes), or else after transfection and
overnight incubation, 107 PC12 or HEK-293 cells were
washed twice with ice-cold phosphate-buffered saline
(PBS, pH 7.4) and harvested by centrifugation at 1,000 ×
g for 5 min at 4°C. Cell pellets were homogenized on iceBMC Biochemistry 2007, 8:18 http://www.biomedcentral.com/1471-2091/8/18
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in a glass Dounce tissue grinder in 0.4 ml of TE buffer (10
mM Tris-HCl, 4 mM EDTA) containing protease inhibi-
tors. The mixture was centrifuged at 1,000 × g for 5 min at
4°C. 150 µl of the supernatant was incubated with 50 µl
of TNE buffer (25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 4
mM EDTA) containing 2 % of Triton X-100 (final Triton
concentration of 0.5%) for 20 min on ice. 200 µl of the
solution was mixed with 900 µl of TNE containing 85.5%
of sucrose in Beckman SW55 tubes. The mixture was over-
laid with 2.5 ml of TNE buffer containing 65% of sucrose
and then with 1.1 ml of TNE buffer containing 10% of
sucrose. The samples were centrifuged in a SW 55Ti rotor
for 20 h at 170,000 × g at 4°C in a Beckman XL-90
Optima ultracentrifuge. Fractionation proceeded from the
top of the gradient (0.47 ml each, for a total of 10 frac-
tions). SDS sample buffer was added to equal aliquots of
each fraction of the gradient and prepared for immunob-
lotting.
Isolation of DRM from adult mouse brain
Lipid rafts were prepared from the synaptosomal fraction
isolated from adult mouse brain according to published
methods, with few modifications [26,30]. Fresh brain was
isolated from an adult Black Swiss mouse and homoge-
nized on ice in a glass Dounce tissue grinder in 16 ml of
ice-cold solution A (0.32 M sucrose, 0.5 mM CaCl2, 1 mM
each of NaHCO3, MgCl2, and orthovanadate, 20 mM of β-
glycerophosphate and 5 µg/ml of leupeptin). After centrif-
ugation at 700 × g for 5 min at 4°, the pellet was washed
with solution A and re-centrifuged at 700 × g for 5 min.
The supernatants were then combined and centrifuged as
above. The resulting supernatant was centrifuged at
15,000 × g for 13 min and the pellet washed and centri-
fuged under the same conditions. The resulting pellet
(P2), designated as crude synaptosomes, was suspended
in 2.5 ml of ice-cold solution B (solution A without CaCl2
and MgCl2). After protein determination, proteins were
solubilized by adding 2 ml of cold solution B containing
1% Triton X-100 per 3 mg protein of crude synaptosomes,
followed by end-over-end mixing for 30 min at 4°C. The
crude solubilizate was adjusted to 41% sucrose, and over-
laid with 8 ml of 35% sucrose in solution B and 2.5 ml of
16% sucrose in solution B. DRM fractions were isolated by
ultracentrifugation at 35,000 rpm, for 18 h, 4°C, using an
SW41 rotor (Beckman Instruments Inc). Fractionation
proceeded from the top of the gradient (1 ml each, for a
total of 11 fractions). SDS sample buffer was added to
equal aliquots of each fraction of the gradient and pre-
pared for immunoblotting.
Quantification of protein distribution between DRM and 
non-DRM fractions
The relative intensity of the major immunoreactive
band(s) in each fraction of the sucrose density gradient
was quantified by densitometric scanning using an Alpha
Innotech Gel Imaging System and Alphamager™ 3400
software, as was an adjacent non-immunoreactive region
of identical area (background). The net band density was
obtained after subtraction of the background from the
measured band density. The percentage of total band
intensity represented by the DRM fractions and non-DRM
fractions from cultured cells or mouse brain was deter-
mined by the sum of the density of the bands in fractions
1 to 5 and 6 to 10 respectively, divided by the total density
which is the sum of the density of 10 fractions, multiplied
by 100. Error bars in the histograms in the figures repre-
sent standard errors of the mean from multiple determi-
nations.
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